Atlas Trials

Oxford Biodynamics Inc.

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Oxford Biodynamics Inc.

RecordFirmDate
A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications. (NCT06635954)Oxford Biodynamics Inc.2024-05-14

Track Oxford Biodynamics Inc. automatically

Every clearance here is in the API, with alerts when new ones post.